Molecular chaperones: Guardians of tumor suppressor stability and function.

Q2 Medicine Oncotarget Pub Date : 2024-10-01 DOI:10.18632/oncotarget.28653
Jennifer A Heritz, Sarah J Backe, Mehdi Mollapour
{"title":"Molecular chaperones: Guardians of tumor suppressor stability and function.","authors":"Jennifer A Heritz, Sarah J Backe, Mehdi Mollapour","doi":"10.18632/oncotarget.28653","DOIUrl":null,"url":null,"abstract":"<p><p>The term 'tumor suppressor' describes a widely diverse set of genes that are generally involved in the suppression of metastasis, but lead to tumorigenesis upon loss-of-function mutations. Despite the protein products of tumor suppressors exhibiting drastically different structures and functions, many share a common regulatory mechanism-they are molecular chaperone 'clients'. Clients of molecular chaperones depend on an intracellular network of chaperones and co-chaperones to maintain stability. Mutations of tumor suppressors that disrupt proper chaperoning prevent the cell from maintaining sufficient protein levels for physiological function. This review discusses the role of the molecular chaperones Hsp70 and Hsp90 in maintaining the stability and functional integrity of tumor suppressors. The contribution of cochaperones prefoldin, HOP, Aha1, p23, FNIP1/2 and Tsc1 as well as the chaperonin TRiC to tumor suppressor stability is also discussed. Genes implicated in renal cell carcinoma development-<i>VHL</i>, <i>TSC1/2</i>, and <i>FLCN</i>-will be used as examples to explore this concept, as well as how pathogenic mutations of tumor suppressors cause disease by disrupting protein chaperoning, maturation, and function.</p>","PeriodicalId":19499,"journal":{"name":"Oncotarget","volume":"15 ","pages":"679-696"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444336/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncotarget","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18632/oncotarget.28653","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The term 'tumor suppressor' describes a widely diverse set of genes that are generally involved in the suppression of metastasis, but lead to tumorigenesis upon loss-of-function mutations. Despite the protein products of tumor suppressors exhibiting drastically different structures and functions, many share a common regulatory mechanism-they are molecular chaperone 'clients'. Clients of molecular chaperones depend on an intracellular network of chaperones and co-chaperones to maintain stability. Mutations of tumor suppressors that disrupt proper chaperoning prevent the cell from maintaining sufficient protein levels for physiological function. This review discusses the role of the molecular chaperones Hsp70 and Hsp90 in maintaining the stability and functional integrity of tumor suppressors. The contribution of cochaperones prefoldin, HOP, Aha1, p23, FNIP1/2 and Tsc1 as well as the chaperonin TRiC to tumor suppressor stability is also discussed. Genes implicated in renal cell carcinoma development-VHL, TSC1/2, and FLCN-will be used as examples to explore this concept, as well as how pathogenic mutations of tumor suppressors cause disease by disrupting protein chaperoning, maturation, and function.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
分子伴侣:肿瘤抑制因子稳定性和功能的守护者
肿瘤抑制因子 "一词描述了一系列种类繁多的基因,这些基因通常参与抑制转移,但一旦发生功能缺失突变,就会导致肿瘤发生。尽管肿瘤抑制因子的蛋白质产物在结构和功能上存在巨大差异,但许多肿瘤抑制因子都有一个共同的调控机制--它们都是分子伴侣的 "客户"。分子伴侣的客户依赖于细胞内的伴侣和辅助伴侣网络来维持稳定性。肿瘤抑制因子的突变会破坏正常的伴侣作用,从而使细胞无法维持足够的蛋白质水平以发挥生理功能。本综述讨论分子伴侣 Hsp70 和 Hsp90 在维持肿瘤抑制因子的稳定性和功能完整性方面的作用。此外,还讨论了辅助伴侣预折叠素、HOP、Aha1、p23、FNIP1/2 和 Tsc1 以及伴侣素 TRiC 对肿瘤抑制因子稳定性的贡献。我们将以与肾细胞癌发展有关的基因--VHL、TSC1/2 和 FLCN 为例,探讨这一概念,以及肿瘤抑制因子的致病突变如何通过破坏蛋白质的伴侣作用、成熟和功能而导致疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Oncotarget
Oncotarget Oncogenes-CELL BIOLOGY
CiteScore
6.60
自引率
0.00%
发文量
129
审稿时长
1.5 months
期刊介绍: Information not localized
期刊最新文献
Advancements in cell-penetrating monoclonal antibody treatment. B7-H4: A potential therapeutic target in adenoid cystic carcinoma. Computed tomography-based radiomics and body composition model for predicting hepatic decompensation. Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists. Retraction: Hyperglycemia via activation of thromboxane A2 receptor impairs the integrity and function of blood-brain barrier in microvascular endothelial cells.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1